Skip to main content
U

Uncommon

Uncommon is developing a scalable production process for cultivated meat that eliminates the primary cost driver in the industry without genetic engineering. Their products, such as Uncommon Bacon and Uncommon Belly, provide a nutritious and sustainable alternative to traditional pork, significantly reducing waste and improving consumer health.

Cambridge, United Kingdom · HQ
Founded 2019607K+ followers
  • Biotechnology
Updated 22 months ago

Funding

Raised to date

$49.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Balderton CapitalNo round attributed
  • Source unavailable
Eastx VenturesNo round attributed
Global BrainNo round attributed
LowercarbonNo round attributed
  • Source unavailable
Funding rounds are not available yet.

Founders

1 founder

David Breslauer

Co-Founder/Chief Technology Officer

Product

Problem

Traditional pork production methods are environmentally unsustainable, contribute to animal welfare concerns, and can pose risks to human health through zoonotic diseases and antibiotic resistance. Scaling cultivated meat production faces challenges related to cost, efficiency, and achieving sensory parity with conventionally produced pork.

Solution

Uncommon is developing cultivated pork products, such as bacon and pork belly, using cell-based agriculture to offer a sustainable and ethical alternative to traditional pork. The company focuses on optimizing a scalable production process that reduces the primary cost drivers in cultivated meat manufacturing without relying on genetic engineering. Uncommon's approach aims to minimize waste, improve consumer health, and provide a more environmentally friendly option compared to conventional pork production. By cultivating meat directly from cells, Uncommon seeks to address the limitations of traditional agriculture and create a more resilient and responsible food system.

Target Audience

Uncommon's target audience includes environmentally conscious consumers, flexitarians, and individuals seeking healthier and more ethical meat options, as well as food manufacturers and retailers looking to expand their sustainable product offerings.

Features

  • Proprietary cell lines optimized for efficient growth and differentiation into muscle and fat tissues
  • Serum-free cell culture media to reduce costs and improve scalability
  • Advanced bioprocess engineering for high-density cell cultivation in bioreactors
  • Novel scaffolding techniques to create structured meat products with realistic texture
  • Lipidomics-based approach to optimize the nutritional profile and flavor of cultivated pork
  • End-to-end process control and monitoring to ensure product safety and consistency
This profile is AI-generated and may contain inaccuracies.